Élizabeth Fabre-Guillevin

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Retroperitoneal liposarcomas: Follow‐up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas

Élizabeth Fabre-Guillevin, Jean‐Michel Coindre, Nicolas de Saint Aubain Somerhausen et al. · Cancer · 2006 · 114 citations · Full text

Medicine, Oncology, Pathology +17

Impact of on-site initiation visits on patient recruitment and data quality in a randomized trial of adjuvant chemotherapy for breast cancer

J-L Liénard, Emmanuel Quinaux, Élizabeth Fabre-Guillevin et al. · Clinical Trials · 2006 · 49 citations · Full text

Medicine, Oncology, Breast Oncology +16

Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma

Hélène Blons, Karine Pallier, Delphine Le Corre et al. · BMC Medical Genomics · 2008 · 39 citations · Full text

Medicine, Genetics, Oncology +17

Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: An observational study

Christophe Locher, Élizabeth Fabre-Guillevin, Francesco Brunetti et al. · Critical Reviews in Oncology/Hematology · 2008 · 29 citations

Medicine, Oncology, Pharmacology +10